openPR Logo
Press release

Global Bioabsorbable Stents Market Set for Significant Growth, Expected to Reach USD 253.9 Million by 2033 Driven by Advancements in Manufacturing Technology and Emerging Markets

12-20-2024 07:30 AM CET | Health & Medicine

Press release from: Future Market Insights Inc

Bioabsorbable Stents Market

Bioabsorbable Stents Market

The global bioabsorbable stents market is poised for substantial growth, with projections indicating a rise in market value from USD 171.8 million in 2023 to an impressive USD 253.9 million by 2033. This growth represents a steady Compound Annual Growth Rate (CAGR) of 4%, reflecting the increasing global demand for innovative cardiovascular treatment options.

Transformative Trends in Stent Development:
The stent development landscape is undergoing a revolutionary transformation, fueled by advanced manufacturing techniques that are reshaping the industry. With a range of innovative modalities now at their disposal, manufacturers are well-positioned to leverage emerging opportunities in the bioabsorbable stents market. Five primary techniques are currently being utilized for stent production: etching laser cutting, electroforming, micro-electro discharge machining, and die-casting.

Discover Market Shifts: Secure Your Sample Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-4819

One of the most noteworthy advancements in recent years is the adoption of 3D printing technology. Traditional processing methods for biodegradable stent materials have faced limitations, prompting the rise of biological 3D printing technology. This cutting-edge development is enabling the creation of more customized and precise solutions, catering to the evolving needs of the market.

Emerging Markets and Future Prospects:
As the demand for advanced cardiovascular solutions escalates, emerging economies, particularly in Asia, present significant growth opportunities for the bioabsorbable stents market. Countries such as China are becoming key focal points for manufacturers seeking to capitalize on the growing need for innovative medical devices. This strategic shift towards emerging markets is expected to further drive the expansion of the bioabsorbable stents market.

The global bioabsorbable stents market is on the cusp of a transformative period, with technological innovations and emerging markets providing significant momentum for future growth. Manufacturers are encouraged to adapt to these transformative trends and capitalize on the numerous opportunities arising in this promising sector. As the market continues to evolve, bioabsorbable stents are expected to play a crucial role in addressing the growing demand for effective and sustainable cardiovascular treatments worldwide.

"Market players can expand their share in China for bioabsorbable stents, due to significant opportunities present in this market. However, they must take into account the preference for value products as the government is forcing a decrease in the overall product prices. Additionally, they must look out for the long-term viability of the product," says an FMI analyst.

Key Takeaways from the Bioabsorbable Stents Market Report:
• In 2022, the global bioabsorbable stents market size stood at USD 167.7 million.

• North America is a notable market for bioabsorbable stents, accounting for about 48.5% in 2023. The United States occupied 44.4% market share in 2022.

• The Europe market for bioabsorbable stents gathered a market share of 27.6% in 2022. The German market, a core market in the region, procured a value share of 9.9% in 2022.

• The United Kingdom market is predicted to expand at a CAGR of 5.7% through 2033.

• Within Asia Pacific, China and India are predicted to register CAGRs of 6.6% and 4.6% through 2033.

• Based on product type, the coronary artery stents segment is expected to acquire a value share of around 76.2% in 2023.

• On the basis of material type, the polymers segment is anticipated to obtain a market share of about 59.3% in 2023.

Stay Ahead with Bioabsorbable Stents: Delve into Our Full Report for Extensive Trends and Insights! https://www.pharmiweb.com/press-release/2024-06-17/global-bioabsorbable-stents-market-poised-for-significant-growth-projected-to-reach-usd-2539-milli

Recent Developments Detected in the Bioabsorbable Stents Market:
• In September 2020, Abbott Laboratories commenced the launch of the LIFE-BTK clinical trial to assess the Espirit below-the-knee drug-eluting resorbable scaffold. The firm reported that this is its first trial in the United States to examine an entirely resorbable device to cure blocked arteries critical limb ischemia (CLI) and below the knees in patients suffering from severe stages of peripheral artery disease (PAD).

• In April 2020, Boston Scientific announced the launch of Synergy Megatron, which is a bioabsorbable polymer coronary stent system. The device boasts of invigorated strength and capacity to accommodate reduced vessels. This medical device has made its debut in Europe.

• In August 2022, PGIMER executed the first-ever robotically-assisted biodegradable stent implantation. These newer bioresorbable stents with thinner struts, which have been developed in India, dissolve in the body post three years, leaving the natural artery as it is.

Key Players in the Market:
• Boston Scientific Corporation
• Meril Life Sciences Pvt. Ltd.
• Medtronic Plc
• Smith & Nephew Plc
• Stryker Corporation
• Wright Medical Group
• KLS Martin
• BIOTRONIK Ltd
• Syntellix AG
• Q3 Medical Devices Limited.
• JW Medical Systems LTD
• ORBUSNEICH MEDICAL
• Abbott Vascular

Key Market Segments Covered in Bioabsorbable Stents Market Report:
By Stents:
• Coronary Artery Stents
• Peripheral Artery Stents
• Non-vascular Stents
o Esophageal Stents
o Billary Stents

By Material:
• Metallic
• Ceramic
• Polymers
o PGA
o PLA
o Co-Polymer

By Application:
• Cardiovascular
• Orthopedics
• Cosmetic Surgery
• General Surgery
• Cranial
• Others

By End User:
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈'𝐬 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐎𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:

Helicobacter Pylori Testing Market https://www.fmiblog.com/2024/12/02/global-helicobacter-pylori-testing-market-set-for-significant-growth-projected-to-reach-usd-380-3-million-by-2032/

Head Band Ophthalmoscopes Market https://www.fmiblog.com/2024/12/02/global-head-band-ophthalmoscopes-market-set-for-robust-growth-projected-to-reach-usd-72-9-million-by-2032/

Wound Evacuators Market https://www.fmiblog.com/2024/12/02/promising-growth-ahead-for-the-global-wound-evacuators-market-expected-to-reach-usd-593-6-million-by-2032/

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Bioabsorbable Stents Market Set for Significant Growth, Expected to Reach USD 253.9 Million by 2033 Driven by Advancements in Manufacturing Technology and Emerging Markets here

News-ID: 3793447 • Views:

More Releases from Future Market Insights Inc

Endoscopy Fluid Management Systems Market Poised for Significant Growth, Projected to Surpass USD 1.1 Billion by 2035 Key Players Hologic Inc, B. Braun Medical Inc., Medtronics Plc., Cantel Medical Corporation and Others
Endoscopy Fluid Management Systems Market Poised for Significant Growth, Project …
The global Endoscopy Fluid Management Systems Market is on a trajectory of significant expansion, with a new market forecast projecting its value to more than double over the next decade. According to the latest analysis, the market, valued at an estimated USD 550.3 million in 2025, is expected to surge to USD 1,123.7 million by 2035. This robust growth represents a compound annual growth rate (CAGR) of 7.4% and is
NGS Sample Preparation Market Poised for Explosive Growth, Set to Triple by 2035 Key Players Macrogen, Inc., Eurofins Scientific, Illumina, Inc., F Hoffman-La Roche AG and Others
NGS Sample Preparation Market Poised for Explosive Growth, Set to Triple by 2035 …
A new market analysis projects the global Next-Generation Sequencing (NGS) Sample Preparation market to experience a significant surge, forecasting a valuation of USD 7.0 billion by 2035. This marks a substantial increase from its estimated USD 1.9 billion value in 2025, reflecting a robust Compound Annual Growth Rate (CAGR) of 13.7% over the decade. The findings underscore the pivotal role of sample preparation in the expanding field of genomics, driven
Eye and Face Protection Market USD 2.3 Billion by 2035 Key Players Medline Industries, Cardinal Health Inc., DMC Medical Ltd., Lifelong Meditech (Group) and Others
Eye and Face Protection Market USD 2.3 Billion by 2035 Key Players Medline Indus …
The global Eye and Face Protection Market is poised for significant expansion, with a new forecast predicting it will grow from an estimated USD 859.3 million in 2025 to USD 2,332.2 million by 2035. This robust growth trajectory represents a compound annual growth rate (CAGR) of 10.5% over the forecast period, driven by a confluence of rising industrial safety awareness, stringent regulatory mandates, and technological innovation. Click Here for More Information:-
Dermatology Excimer Lasers Market to Nearly Triple by 2035 Key Players Cutera, Inc., The Daavlin Company, Shenzhen GSD Tech Co., Ltd., DEKA Research & Development Corp and Others
Dermatology Excimer Lasers Market to Nearly Triple by 2035 Key Players Cutera, I …
The global market for dermatology excimer lasers is projected to surge from an estimated USD 109.7 million in 2025 to a remarkable USD 317.1 million by 2035, marking a significant compound annual growth rate (CAGR) of 11.2%. This substantial expansion is being fueled by a combination of factors, including the rising global prevalence of chronic skin conditions and a growing preference for advanced, targeted therapies. Click Here for More Information:- https://www.futuremarketinsights.com/reports/dermatology-excimer-lasers-market Dermatology

All 5 Releases


More Releases for Stent

Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lung
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on an
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients